Social Media

LFL -Integrated Care in Sickle Cell Disease: Role of Primary, Secondary and Tertiary care

0 0

SCAGO Community Blood Drive & Engagement Event

2 0

Youth Empowerment Program 2025 graduation event

2 0

SCAGO GTA CHAPTER CHRISTMAS PARTY 2025

Watch this beautiful recap of the most fun and successful SCAGO GTA Chapter Christmas party so far!

0 0

LFL-Clinical Trials 101 What Every Patient Should Know Before Enrolling

1 0

SCAGO Peer Support Session: About the Patient Advocacy & Advisory Council

This SCAGO Peer Support group meeting introduced the Patient Advocacy and Advisory Council (PAAC) and its mission to support the sickle cell disease community through various advocacy efforts and initiatives. The session highlighted the diverse backgrounds and roles of PAAC members, including their work in addressing systemic healthcare issues, promoting community health, and improving access to therapies and clinical trials.

The meeting covered current projects focused on gathering data to improve patient care, discussed available resources and support channels, and concluded with information about upcoming events and a reminder of PAC's dedication to supporting the sickle cell community.

3 0

SCAGO Hospital Experience Reporting Portal

Have you ever received Sickle Cell Disease Care in an Ontario Hospital? If so, please share your experience with us today.

Our HOSPITAL EXPERIENCE REPORTING PORTAL (HERP) allows you to document your experience — and drive change in the healthcare system.
Your feedback is confidential and will help SCAGO recognize the hospitals providing quality or sub-quality care, and advocate for improved access to equitable care by people living with sickle cell disease across Ontario.

You can access the portal here: https://tinyurl.com/HERPSCAGO

0 0

Clinician Track: Spotting and Treating Acute Chest Syndrome & Pulmonary Hypertension Effectively

Session Objectives:
1. Recognize early clinical and radiologic signs of acute chest syndrome and PH.
2. Initiate appropriate acute and long-term management strategies.
3. Evaluate patients for PH risk and refer for specialized care as needed.

4 0

What’s Hot in Cell and Gene Therapy: Which Should I recommend and when?

Session Objectives:
1. Educate providers on eligibility and patient selection for new therapies.
2. Provide clinical support tools to assist in therapy recommendation decisions.
3. Support post-marketing research on safety and efficacy.

1 0